A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...
Protein‐polymer conjugates represent a dynamic class of hybrid materials that combine the inherent biological function and specificity of proteins with the versatile properties of synthetic polymers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results